Citation

Mitchell LH, Boriack-Sjodin PA, Smith S, Thomenius M, Rioux N, Munchhof M, Mills JE, Klaus C, Totman J, Riera TV, Raimondi A, Jacques SL, West K, Foley M, Waters NJ, Kuntz KW, Wigle TJ, Scott MP, Copeland RA, Smith JJ, Chesworth R.: Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor. ACS Med Chem Lett, Volume 7 (2), 2016

Authors

Boriack-Sjodin PA, Chesworth R., Copeland RA, Foley M, Jacques SL, Klaus C, Kuntz KW, Mills JE, Mitchell LH, Munchhof M, Raimondi A, Riera TV, Rioux N, Scott MP, Smith JJ, Smith S, Thomenius M, Totman J, Waters NJ, West K, Wigle TJ

Journal

ACS Med Chem Lett

Year

2016

DOI

10.1021/acsmedchemlett.5b00272

PubMed

26985287

Machine-readable

REST APIRDF